300238 冠昊生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.7955.1596.165-48.5049.733
总资产报酬率 ROA (%)3.4953.8274.597-34.8026.598
投入资产回报率 ROIC (%)3.7794.2565.169-39.4197.594

边际利润分析
销售毛利率 (%)77.69579.46279.12676.24675.114
营业利润率 (%)10.7137.4828.409-77.40616.679
息税前利润/营业总收入 (%)11.8697.7849.263-76.08618.174
净利润/营业总收入 (%)6.9614.4005.214-86.84110.376

收益指标分析
经营活动净收益/利润总额(%)100.160151.827136.150-5.83481.748
价值变动净收益/利润总额(%)0.5972.164-11.3443.760-5.710
营业外收支净额/利润总额(%)2.111-0.801-5.9190.1850.608

偿债能力分析
流动比率 (X)1.9751.4931.5471.5821.660
速动比率 (X)1.4261.0521.1331.2551.124
资产负债率 (%)36.28338.01832.76435.70631.907
带息债务/全部投入资本 (%)17.57216.1857.29610.3719.534
股东权益/带息债务 (%)447.377488.3091,184.959783.020852.859
股东权益/负债合计 (%)203.592189.102234.149202.793223.610
利息保障倍数 (X)12.83121.5416.999-51.98313.049

营运能力分析
应收账款周转天数 (天)49.45757.54959.28485.24882.110
存货周转天数 (天)334.006348.411284.357406.164395.607